Gait Speed Change During First Chemotherapy Cycle May Predict Later Dose-Reduction in Ovarian Cancer Patients over 70: an Exploratory Analysis

With chemotherapy (chemo) increasingly offered over age 70 in ovarian cancer (OC), clinically feasible predictors of chemo tolerance are needed. We conducted a secondary analysis in older OC patients, to explore how gait speed & grip strength trajectories relate to adverse events (AE) over a course of chemotherapy in older women.